NASDAQ:OBX | News | Obsidian Therapeutics, Inc.

OBX News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-14Current reportSEC filingObsidian Therapeutics, Inc. filed Form 8-K/AObsidian Therapeutics, Inc. filed Form 8-K/A covering items 9.01.
2026-08-03Current reportSEC filingObsidian Therapeutics, Inc. filed Form 8-KObsidian Therapeutics, Inc. filed Form 8-K covering items 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,7.01,9.01.